Decision Aids for Preventive Treatment Alternatives for BRCA1/2 Mutation Carriers: a Systematic Review

Introduction Women with a pathogenic BRCA1/2 mutation have a markedly increased lifetime risk of developing breast and/or ovarian cancer. The current preventive treatment alternatives that are offered are an intensified breast cancer screening programme and risk-reducing operations. Before deciding...

Descripción completa

Detalles Bibliográficos
Autores principales: Krassuski, Lisa Marlene, Kautz-Freimuth, Sibylle, Vennedey, Vera, Rhiem, Kerstin, Schmutzler, Rita K., Stock, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216782/
https://www.ncbi.nlm.nih.gov/pubmed/34168381
http://dx.doi.org/10.1055/a-1326-1792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216782/
https://www.ncbi.nlm.nih.gov/pubmed/34168381
http://dx.doi.org/10.1055/a-1326-1792

Ejemplares similares